Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status

This article is protected by copyright. All rights reserved.

Source: International Journal of Cancer - October 6, 2015 Category: Cancer & Oncology Authors: Junko Kato, Manabu Futamura, Masako Kanematsu, Siqin Gaowa, Ryutaro Mori, Toshiyuki Tanahashi, Nobuhisa Matsuhashi, Kazuhiro Yoshida Tags: Research Article Source Type: research